Cancer Drugs - FOI Response Register

FoI Number
2024-363
Subject
Cancer Drugs
Date Received
07/10/2024
Request and Response
  1. In the past 6 months, at your trust how many patients were treated with a combination of Dabrafenib + Trametinib for the following conditions:

A) Metastatic Melanoma

B) Adjuvant Melanoma

C) BRAF mutated Lung Cancer

Nil

  1. In the past 6 months, at your trust how many patients were treated with a combination of Encorafenib (Braftovi) + Binimetinib (Mektovi) for the following conditions:

A) Metastatic Melanoma

B) Colorectal Cancer

Nil